Mirae Asset Global Etfs Holdings Ltd. Alkermes Plc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 95,465 shares of ALKS stock, worth $2.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
95,465Holding current value
$2.66 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$810 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$557 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$399 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$306 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$256 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.57B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...